Scienture Holdings (SCNX) EBT Margin (2013 - 2026)
Scienture Holdings' (SCNX) quarterly EBT Margin came in at 821.32% in Q2 2026, up 86.45% quarter-over-quarter from 6059.79% in Q1 2026.
Analysis
Scienture Holdings (SCNX) EBT Margin (2013 - 2026) Analysis & Trends
Scienture Holdings has disclosed EBT Margin across 14 years of filings, most recently posting 821.32% for Q2 2026.
- In Q2 2026, EBT Margin changed N/A year-over-year to 821.32%; the TTM figure through Jun 2026 stood at 3905.23% (down 430379.0% YoY), while the FY2025 annual figure was 10080.22%, up 366280.0% from the prior year.
- EBT Margin came in at 821.32% for Q2 2026 at Scienture Holdings, up from 6059.79% in the prior quarter.
- In the past five years, EBT Margin ranged from a high of 87.23% in Q4 2023 to a low of 29869.34% in Q1 2025.
- Average EBT Margin over 5 years is 3829.51%, with a median of 127.64% recorded in 2022.
- Year-over-year, EBT Margin plunged 847597 bps in 2024 and jumped 2380956 bps in 2026.
- Over 5 years, EBT Margin stood at 80.08% in 2022, then soared by 209 bps to 87.23% in 2023, then sank by 10061 bps to 8688.92% in 2024, then slumped by 244 bps to 29869.34% in 2025, then soared by 97 bps to 821.32% in 2026.
- Per Business Quant data, the three most recent EBT Margin figures were 821.32% in Q2 2026, 6059.79% in Q1 2026, and 29869.34% in Q1 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.27 Bn | 38.61 Bn | 2.15 Bn | -10.99% |
| 2 | Viatris | 18.80 Bn | 17.92 Bn | 1.46 Bn | -1.70% |
| 3 | Dr Reddys Laboratories | 9.73 Bn | 9.56 Bn | 396.53 Mn | 6.85% |
| 4 | Amneal Pharmaceuticals | 5.41 Bn | 5.29 Bn | 334.51 Mn | 8.92% |
| 5 | Bausch Health Companies | 2.29 Bn | 457.00 Mn | 2.10 Bn | 12.20% |
| 6 | Alvotech | 1.54 Bn | 1.40 Bn | 2.56 Mn | -121.92% |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | 13.94% |
| 8 | Amphastar Pharmaceuticals | 1.01 Bn | 722.85 Mn | 93.47 Mn | 20.96% |
| 9 | Fennec Pharmaceuticals | 397.61 Mn | 356.36 Mn | 17.15 Mn | 11.27% |
| 10 | Scienture Holdings | 14.42 Mn | 14.42 Mn | 335,779.00 | -821.32% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -821.32% |
| Mar 31, 2026 | -6,059.79% |
| Mar 31, 2025 | -29,869.34% |
| Jun 30, 2024 | -8,688.92% |
| Dec 31, 2023 | 87.23% |
| Sep 30, 2023 | -53.30% |
| Jun 30, 2023 | -212.95% |
| Mar 31, 2023 | -175.20% |
| Dec 31, 2022 | -80.08% |
| Sep 30, 2022 | -16.56% |
| Jun 30, 2022 | -33.92% |
| Mar 31, 2022 | -29.93% |
| Dec 31, 2021 | -32.85% |
| Sep 30, 2021 | -51.05% |
| Jun 30, 2021 | -135.82% |
| Mar 31, 2021 | -21.34% |
| Dec 31, 2020 | -115.94% |
| Sep 30, 2020 | 2.19% |
| Jun 30, 2020 | -8.23% |
| Mar 31, 2020 | 8.18% |